PURPOSE: @entity64 may cause or worsen @entity323 ( @entity323 ). Post- @entity64 @entity323 prevalence and association with @entity64 location are not well established. Therefore, we assessed post- @entity64 @entity323 prevalence in relation to @entity2806 locations and @entity64 severity. METHODS: In 57 @entity1 (62.6      10.5  years) who had @entity385 within 24  months prior to evaluation, we used the five-item International Index of Erectile Function questionnaire (IIEF5) to evaluate @entity323 prevalence after @entity64 and retrospectively 3  months prior to @entity64 . IIEF5 scores range from 5 to 25; scores below 22 indicate @entity323 . We estimated @entity64 severity upon hospital admission, using the National Institute of Health @entity64 Scale (NIHSS), and determined @entity64 location from cranial computed tomography or magnetic resonance imaging. We compared pre- and post- @entity64 results with those of 22 control @entity1 (61.7      11.2  years), calculated correlations between IIEF5 scores and NIHSS scores, and compared @entity323 prevalence with @entity64 locations (significance: p  <  0.05). RESULTS: @entity323 was reported by 45/57 @entity1 after @entity64 , 26/57 @entity1 before @entity64 , and 6/22 control @entity1 . @entity1 ' IIEF5 values were significantly lower [median 16 interquartile range (IQR) 3.5-20.5] after than before @entity64 (median 23, IQR 19.0-24.0) and lower than in controls (median 24, IQR 19.8-25.0). Pre- and post- @entity64 IIEF5 scores did not correlate with the @entity1 ' NIHSS scores at @entity64 onset (p  >  0.05). @entity323 was associated with @entity2500 in 27/34, @entity1416 in 4/5, anterior cerebral @entity1188 in 1/1, @entity1188 in 3/3, brain stem @entity1188 in 8/10, @entity1188 in 2/5, and lesions in more than one region in 1/1 @entity1 . CONCLUSIONS: Disruption of the central network assuring erection might contribute to increased @entity323 severity and prevalence after @entity64 . Anti-erectile effects of functional and @entity73 or medication added after @entity64 may also contribute to @entity323 but must be evaluated in larger @entity1 groups.

@entity323 ( @entity323 ) after XXXX : association between prevalence and site of lesion.

@entity1 :: ('9606', 'Species') :: ['men', 'Patients', 'patients', 'persons'] @entity323 :: ('MESH:D007172', 'Disease') :: ['erectile dysfunction', 'ED'] @entity64 :: ('MESH:D020521', 'Disease') :: ['stroke', 'Stroke'] @entity2806 :: ('MESH:D002545', 'Disease') :: ['ischemic lesion'] @entity2500 :: ('MESH:D020244', 'Disease') :: ['middle cerebral artery infarction'] @entity73 :: ('MESH:D003072', 'Disease') :: ['psychological impairment'] @entity1416 :: ('MESH:D020762', 'Disease') :: ['posterior cerebral artery infarction'] @entity1188 :: ('MESH:D007238', 'Disease') :: ['artery infarction', 'basal ganglia infarction', 'cerebellar infarction', 'infarction'] @entity385 :: ('MESH:D002544', 'Disease') :: ['ischemic stroke']
@entity385 :: (MESH:D002544,Disease) :: ['ischemic stroke']
